Lexaria Bioscience Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
/ 
Frequently asked questions
To buy Lexaria Bioscience Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lexaria Bioscience Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lexaria Bioscience Corp. is LEXX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lexaria Bioscience Corp. has its primary listing on NASDAQ (Small cap). You can trade Lexaria Bioscience Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lexaria Bioscience Corp. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Lexaria Bioscience Corp. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Lexaria Bioscience Corp..